Serum BDNF was significantly elevated from weeks 0 to 12 (n = 11, 52.4 ± 16.7 vs. 79.8 ± 13.8, p = 0.001), although it was largely unchanged in the two patients who developed PTSD or major depression during the trial. Here, BDNF is linked to major depressive disorder.